Helmholtz-Zentrum Dresden-Rossendorf

Porträt Prof. Dr. Bachmann, Michael; FWPI
Prof. Dr. Michael Bachmann

Director Institute of Radiopharmaceutical Cancer Research

Phone:+49 351 260 3170, +49 172 694 8424, +49 351 458 2101
Email: m.bachmannAthzdr.de
Links:Publikationsliste HZDR
Publikationsliste Web of Science
ORCID: 0000-0002-8029-5755
AddressBautzner Landstraße 400
01328 Dresden


1976-1981 Study of Pharmacy, Johannes Gutenberg University, Mainz
1981 Ph.D., Johannes Gutenberg University, Mainz
1989 Habilitation (Physiological Chemistry)
1997-1999 Professor (APL) of Physiological Chemistry, Johannes Gutenberg University, Mainz
1999-2002 R-Associate Member, OMRF, Immunology and Arthritis Program
2003-2011 Professor of Immunology (Tumorimmunology), Institute of Immunology, Medical Faculty, Technical University of Dresden, Germany
since 2011 Professor for Translational Radiopharmacology, Technical University of Dresden, Germany


1981-1986 Postdoc, Johannes Gutenberg University, Mainz
1987-1991 Research Fellow, Johannes Gutenberg University, Mainz
1991-1997 Group Leader, Johannes Gutenberg University, Mainz
1990-1999 Lecturer of Physiological Chemistry, Johannes Gutenberg University, Mainz
1998 Greenberg-Scholar, OMRF, Immunology and Arthritis Program, OK, USA
1998-2002 R-Associate Member, OMRF, Immunology and Arthritis Program
Since 2003 Lecturer of Immunology, Carl Gustav Carus TU Dresden
Since 2006 Vice chairman of the tumor immology study group of the german society of immunology


1981 Doctoral thesis, summa cum laude
1989 Boehringer-Ingelheim Prize
1990 Award of the German Society of Cell biology
1990 Bruno-Schuler Prize of the German Society of Rheumatology
1991 Stiftungsprofessur from the Stifterverband für die Deutsche Wissenschaft
1991 Robert Feulgen Award of the International Society of Cytochemistry and Histochemistry
1998 Greenberg scholarships at the OMRF, OK, USA

List of peer reviewed publications (Impact factor (IF) in brackets):


Summary published original manuscripts

Total number:                                  237

Overall impact:                                  1136,3

h-Factor:                                            54 (Google Scholar); 51 (RG, Publons, Michael Bachmann)

2022  (IF 43,3)

1.      Nguyen-Le, T.A., Bartsch, T., Wodtke, R., Brandt, F., Arndt, C., Feldmann, A., Sandoval Bojorquez, D.I., Roig, A.P., Ibarlucea, B., Lee, S., Baek, C.K., Cuniberti, G., Bergmann, R., Puentes-Cala, E., Soto, J.A., Kurien, B.T., Bachmann, M., and Baraban, L. (2022). Nanosensors in clinical development of CAR-T cell immunotherapy. Biosens. Bioelectron. 206:114124. doi: 10.1016/j.bios.2022.114124. PMID: 35272215.                                                                (IF 10,3).

2.      Brandt, F., Ullrich, M., Laube, M., Kopka, K., Bachmann, M., Löser, R., Pietzsch, J. Pietzsch, H.J., van den Hoff, J., and Wodtke, R. (2021). Clickable” albumin binders for modulating the tumor uptake of targeted radiopharmaceuticals. J. Med. Chem., i65:710-733. doi: 10.1021/acs.jmedchem.1c01791. Epub 2021 Dec 23. PMID: 34939412.            (IF 7,5).

3.      Köseer, A.S., Loureiro, L.R., Jureczek, J., Mitwasi, N., Gonzalez Soto, K.E., Aepler, J., Bartsch, T., Feldmann, A., Kunz-Schughart, L., Linge, A., Krause, M., Bachmann, M., Arndt, C., and Dubrovska, A. (2022). Validation of CD98hc as a therapeutic target for a combination of radiation and immunotherapies in head and neck squamous cell carcinoma. Cancers, under revision                                                                                                                         (IF 6,6).

4.      Kubeil, M., Santana Martinez, I.I., Bachmann, M., Kopka, K., Tuck, K.L., and Stephan, H. (2022). Dual-Labelling strategies for nuclear and fluorescence molecular imaging: Current status and future perspectives. Pharmaceuticals, submitted.

                                                                                                                                                                                                (IF 5,9).

5.      Arndt, C., Bergmann, R., Striese, F., Merkel, K., Máthé D., Loureiro, L., Mitwasi, N., Kegler, A., Fasslrinner, F., Soto Gonzalez, K.E., Neuber, C., Berndt, N., Kovacs, N., Szöllősi, D., Hegedűs, N., Toth, G., Emmermann, J.-P., Harikumar, K.B., Kovacs, T., Bachmann, M., and Feldmann, A. (2022). Adaptor CAR T cell based radio-/immunotheranostics for targeting of prostate cancer. Cancers, submitted.                                                                                             (IF 6,6).

6.      Plesca, I., Benešova, I., Beer, C., Sommer, U., Müller, L., Wehner, R., Heiduk, M., Aust, D., Baretton, G., Bachmann, M.P., Feldmann, A., Weitz, J., Seifert, L., Seifert, A.M., and Schmitz, M. (2022). Clinical significance of tumor-infiltrating conventional and plasmacytoid dendritic cells in pancreatic ductal adenocarcinoma. Cancers, in press.                                                                                                                                                                                                              (IF 6,6).


2021  (IF 85,3)

7.      Kießler, M., Plesca, J., Sommer, U., Wehner, R., Wilczkowski, F., Müller, L., Tunger, A., Lai, X., Rentsch, A., Peuker, K., Zeissig, S., Seifert, A., Seifert, L., Weitz, J., Bachmann, M., Bornhäuser, M.,  Aust, D., Baretton, G., and Schmitz, M. (2021). Increased frequencies of tumor-infiltrating plasmacytoid dendritic cells are associated with good prognosis in human colon cancer. Journal for ImmunoTherapy of Cancer, 9(3):e001813. doi: 10.1136/jitc-2020-001813. PMID: 33762320                                                                                                                                                                                           (IF 10.3). 

8.      Bartsch, T., Arndt, C., Loureiro, L.R., Kegler, A., Kurien, B.T., Feldmann, A., and Bachmann, M. (2021). A small step a giant leap: Somatic hypermutation of a single amino acid leads to anti-La autoreactivity. Int. J. Mol. Sci., 22:12046. doi: 10.3390/ijms222112046. PMID: 34769474.                                                                                                (IF 5.9).

9.      Kittel-Boselli, E., González Soto, K., Loureiro, L.R., Hoffmann,  A., Bergmann, R., Arndt, C., Koristka, S., Mitwasi, N., Kegler, A., Bartsch, T., Berndt, N., Altmann, H., Fasslrinner, F., Bornhäuser, M., Bachmann, M.P., Feldmann, A. (2021). Targeting Acute Myeloid Leukemia using the RevCAR Plat-form: a Programmable, Switchable and Combinatorial Strategy. Cancers, 24;13(19):4785. doi: 10.3390/cancers13194785. PMID: 34638268                                           (IF 6.6).

10.    Bachmann, M. P., Bartsch, T., Bippes, C.C., Bachmann, D., Puentes-Cala, E., Bachmann, J., Bartsch, H., Arndt, C., Koristka, S., Loureiro, L.R., Kegler, A., Laube, M., Gross, J.K., Gross, T., Kurien, B.T., Scofield, R.H., Farris, A.D., James, J.A., Schmitz, M., and Feldmann, A. (2021). T cell mediated conversion of a non-anti-La reactive B cell to an autoreactive anti-La B cell by somatic hypermutation. Int. J. Mol. Sci., 22(3):1198. doi: 10.3390/ijms22031198. PMID: 33530489                                                                                                                                                                                              (IF 5.9).

11.    Berndt, N., Bippes, C.C., Bartsch, T., Bachmann, D., Puentes-Cala, E., Bachmann, J., Bartsch, H., Arndt, C., Koristka, S., Loureiro, L.R., Kegler, A., Laube, M., Gross, J.K., Gross, T., Kurien, B.T., Scofield, R.H., Farris, A.D., James, J.A., Schmitz, M., Feldmann, A., Arndt, C., and Bachmann, M. P. (2021). Two be or not two be: Redox dependent oligomerization of the nuclear autoantigen La/SS-B. Int. J. Mol. Sci., 22(18):9699. doi: 10.3390/ijms22189699. PMID: 34575862.                                                                                                                                                                                                     (IF 5.9).

12.    Berndt, N., Bippes, C.C., Michalk, I., Bartsch, T., Arndt, C., Puentes-Cala, E., Javier Andrés Soto, Loureiro, L.R., Kegler, A., Bachmann, D., Gross, J.K., Gross, T., Kurien, B.T., Scofield, R.H., Farris, A.D., James, J.A., Bergmann, R., Schmitz, M., Feldmann, A., and Bachmann, M. P. (2021). And yet it moves: Oxidation of the Nuclear Autoantigen La/SS-B is the Driving Force for Nucleo-Cytoplasmic Shuttling. Int. J. Mol. Sci., 8;22(18):9699. doi: 10.3390/ijms22189699. PMID: 34575862                                                                                                                                                           (IF 5.9).

13.    Striese, F., Weißflog, S., Sihver, W., Feldmann, A., Arndt, C., Ullrich, M., Steinbach, J., Pietzsch, J., Bergmann, R., Pietzsch, H.J., and Bachmann, M. P. (2021). 1,4-6*Preclinical characterization of the 177Lu-labeled prostate stem cell antigen (PSCA)-specific monoclonal antibody 7F5 as a potential immunotheranostic agent for prostate cancer. Int. J. Mol. Sci., rev. Ms. Under revision.                                                                                                                     (IF 5.9).

14.    Seliger, B., Subbarayan, K., Ulagappan, K., Wickenhauser, C., and Bachmann, M. (2021). Immune interaction map of human SARS-CoV-2 target genes: implications for therapeutic avenues. Front. Immunol., 12:597399. doi: 10.3389/fimmu.2021.597399. eCollection 2021. PMID: 33796097                                                              (IF 7.6).

15.    Ditte, K., Nguyen Le, T.A., Ditzer, O., Sandoval Bojorquez, D.I., Chae, S., Bachmann, M., Baraban, L., and Lissel, F. (2021). Rapid detection of SARS-CoV-2 antigens and antibodies using OFET biosensors based on a soft and stretchable semiconducting polymer. ACS Biomaterials Sci. and Eng., 10.1021/acsbiomaterials.1c00727. Online ahead of print. PMID: 34519484                                                                                                                                                              (IF 4.2).

16.    Zhao, X., Illing, R., Ruelens, P., Bachmann, M., Cuniberti, G., de Visser, J. A. G. M., and Baraban, L. (2021). Coexistence of fluorescent Escherichia coli strains in millifluidic droplet reactors. Lab Chip. 2021 Apr 20;21(8):1492-1502. doi: 10.1039/d0lc01204a.                                                                                                                                               (IF 7.2).

17.    Tunger, A., Arndt, C., Luttosch, S., Hannemann, K., Koristka, S., Loureiro, L.R., Feldmann, A., Wehner, R., Tonn, T., Link, T., Kuhlmann, J.D., Wimberger, P., Bachmann, M.P., and Schmitz, M. (2021). Palbociclib impairs the proliferative capacity and interferon secretion of activated T cells while retaining their cytotoxic efficacy. Cancers, under revision

                                                                                                                                                                                      (IF 6.6).

18.    Bergmann, R., Chollet, C., Els-Heindl, S., Ullrich, M., Berndt, N., Pietzsch, J., Máthé, D., Bachmann, M., and Beck-Sickinger, A. (2021). Development of a ghrelin receptor inverse agonist for positron emission tomography. Oncotarget, 12(5):450-474. doi: 10.18632/oncotarget.27895. eCollection 2021 Mar 2. PMID: 33747360                                  (IF 3.7).

19.    Strobel, S.B., Machiraju, D., Hülsmeyer, I., Becker, J.C., Paschen, A., Jäger, D., Wels, W.S., Bachmann, M., and Hassel, J.C. (2021). Expression of potential targets for cell-based therapies on melanoma cells. Life, 24;11(4):269. doi: 10.3390/life11040269. PMID: 33805080                                                                                                               (IF 3).

20.    Seifert, V., Richter, S., Bechmann, N., Bachmann, M., Ziegler, C.G., Pietzsch, J., and Ullrich, M. (2021). HIF2alpha-associated pseudohypoxia promotes radioresistance in Pheochromocytoma: Insights from 3D models. Cancers, 13(3):385. doi: 10.3390/cancers13030385. PMID: 33494435                                                                                                      (IF 6,6).


                 2020  (IF 68,4)

21.    Schütt, J., Bojorquez, D.J., Avitabile, E.,. Mata, E.S.O., Milyukov, G., Colditz, J. Delogu, L.G., Rauner, M., Feldmann, A., Koristka, S., Middeke, J.M., Sockel, K., Fassbender, K., Bachmann, M., Bornhäuser, M., Baraban, L., and Cuniberti, G. (2020). Nanocytometer for smart analysis of peripheral blood and acute myeloid leukemia: a pilot study. Nano Letters, in press.                                                                                                                                                                   (IF 12.3).

22.    Arndt, C., Fasslrinner, F., Loureiro, L.-R., Koristka, S., Feldmann, A., and Bachmann, M. (2020). Adaptor CAR platforms - next generation of T cell-based cancer immuno-therapy. Cancers, 21;12(5):E1302. doi: 10.3390/cancers12051302.                                                                                                                                                                                         (IF 6,2).

23.    Feldmann, A., Hoffmann, A., Bergmann, R., Koristka, S., Berndt, N., Arndt, C., Loureiro, L.R., Kittel-Boselli, E., Mitwasi, N., Kegler, A., Lamprecht, C., and Bachmann, M. (2020). Versatile Receptor Platform for Controllable and Combinatorial T Cell Therapy. OncoImmunology, in press.                                                                                                  (IF 5,3).

24.    Arndt, C., Loureiro, L.R., Feldmann, A., Jureczek, J., Bergmann, R., Máthé, D., Hegedüs, N., Berndt, N., Koristka, S., Mitwasi, N., Fasslrinner, F., Lamprecht, C., Kegler, A., Hoffmann, A., Bartsch, T., Köseer, A.S., Egan, G., Schmitz, M., Hořejší, V., Krause, M., Dubrovska, A., and Bachmann, M. (2020). UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells. OncoImmunology, 9: DOI: 10.1080/2162402X.2020.1743036.

                                                                                                                                                                                      (IF 5,3).

25.    Loureiro, L.R., Feldmann, A., Bergmann, R., Koristka, S., Berndt, N., Máthé, D., Hegedüs, N., Videira, P.A., Bachmann, M., and Arndt, C. (2020). Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers. J. ImmunoTherapy Cancer, 39(1):77. doi: 10.1186/s13046-020-01572-4.                                                (IF 8,7).

26.    Loff, S., Dietrich, J., Meyer, J.E., Riewaldt, J., Spehr, J., von Bonin, M., Gründer, C., Swayampakula, M., Franke, K.,  Feldmann, A., Bachmann, M., Ehninger, G., Ehninger, A., and Cartellieri, M. (2020). Rapidly Switchable Universal CAR-T cells for Treatment of CD123-positive Leukemia. Mol. Therapy-Oncolytics, 17:408-420. doi: 10.1016/j.omto.2020.04.009.                                                                                                                                                                                   (IF 5,6).

27.    Mitwasi, N., Feldmann, A., Arndt, C., Koristka, S., Berndt, N., Jureczek, J., Loureiro, L.R., Bergmann, R., Máthé, D., Hegedüs, N., Kovacs, T., Zhang, C., Oberoi, P., Jäger, E., Seliger, B., Rössig, C., Temme, A., Eitler, J., Tonn, T., Schmitz, M., Hassel, J.C., Jäger, D., Wels, W.S., and Bachmann, M. (2020). "UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells. Sci Rep. 10(1):2141. doi: 10.1038/s41598-020-59082-4. PMID: 32034289.

                                                                                                                                                                                      (IF 4,0).

28.    Jureczek, J., Feldmann, A., Bergmann, R., Arndt, C., Berndt, N., Koristka, S., Loureiro, L.R., Mitwasi, N., Hoffmann, A., Kegler, A., Bartsch, T., and Bachmann, M. (2020). Highly efficient targeting of EGFR-expressing tumor cells with UniCAR T cells via target modules based on Cetuximab®. OncoTargets and Therapy, in press.                   (IF 3,0).

29.    Plesca, I., Tunger, A., Müller, L., Wehner, R., Lai, X., Grimm, M.O., Rutella, S., Bachmann, M., and Schmitz, M. (2020) Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy. Front Immunol. 11:364. doi: 10.3389/fimmu.2020.00364. eCollection 2020. Review. PMID: 32194568.     (IF 4,7).

30.    Müller, L., Tunger, A., Plesca, I., Wehner, R., Temme, A., Westphal, D., Meier, F., Bachmann, M., and Schmitz, M. (2020). Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets. Front Immunol. 11:140. doi: 10.3389/fimmu.2020.00140. eCollection 2020. Review. PMID: 32117287.                                        (IF 4,7).

31.    Bauer, M., Vaxevanis, C., Heimer, D., Kathrin, H., Ali, A., Jaekel, N., Bachmann, M., Wickenhauser, C., and Seliger, B. (2020). Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA- Binding Proteins. Int. J. Mol. Sci., 21(19):7140. doi: 10.3390/ijms21197140. PMID: 32992663                                                                                                                                                                  (IF 4,6).

32.    Greifenstein, L., Engelbogen, N., Lahnif, H., Sinnes, J.P., Bergmann, R., Bachmann, M., and Rösch, F. (2020). Synthesis, Labeling and Preclinical Evaluation of a Squaric Acid Containing PSMA Inhibitor Labeled with 68Ga: A Comparison with PSMA-11 and PSMA-617. Chem. Med. Chem. Apr 20;15(8):695-704. doi: 10.1002/cmdc.201900559. Epub 2020 Mar 19. PMID: 32057189.                                                                                                                                           (IF 3,0).

2019  (IF 55)

33.    Singh, G., Zarschler, K., Hunoldt, S., Santana Martínez, I.I., Ruehl, C.L., Matterna, M., Bergmann, R., Máthé, D., Hegedüs, N., Bachmann, M., Comba, P., and Stephan, H.  (2019). Versatile Bispidine-based Bifunctional Chelators for 64CuII-Labelling of Biomolecules. Chemistry. doi: 10.1002/chem.201904654. [Epub ahead of print] PMID: 31755596.                                                                                                                                                                                             (IF 5,2).

34.     Tunger, A., Sommer, U., Wehner, R., Kubasch, A.S., Grimm, M.O., Bachmann, M.P., Platzbecker, U., Bornhäuser, M., Baretton, G., and Schmitz, M. (2019). The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy. J. Clin. Med. 25;8(10). pii: E1534. doi: 10.3390/jcm8101534. Review.                                                        (IF 5,6).

35.     Kegler, A., Koristka, S., Bergmann, R., Berndt, N., Arndt, C., Feldmann, A., Hoffmann, A., Bornhäuser, M., Schmitz, M., and Bachmann, M. (2019). T cells engrafted with a UniCAR 28/ζ outperform UniCAR BB/ζ-transduced T cells in the face of regulatory T cell-mediated immunosuppression. OncoImmunology, Jun 7;8(9):e1621676. doi: 10.1080/2162402X.2019.1621676. eCollection 2019. PMID: 31428518.                                                             (IF 5,5).

36.     Fasslrinner, F., Stölzel, F., Kramer, M., Teipel, R., Brogsitter, C., Morgner, A., Arndt, C., Bachmann, M., Hänel, M., Röllig, C., Kotzerke, J., Schetelig, J., Bornhäuser, M. (2019). Radioimmunotherapy in combination with reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with advanced multiple myeloma. Biol Blood Marrow Transplant. Nov 12. pii: S1083-8791(19)30747-5. doi: 10.1016/j.bbmt.2019.11.007. [Epub ahead of print].

                                                                                                                                                                                     (IF 3,8).

37.     Laube, M., Frizler, M., Wodtke, R., Neuber, C., Belter, B., Kniess, T., Bachmann, M., Gütschow, M., Pietzsch, J. and Löser, R. (2019). Synthesis and preliminary radiopharmacological characterisation of an 11 C-labelled azadipeptide nitrile as potential PET tracer for imaging of cysteine cathepsins. J Labelled Comp Radiopharm. 2019 Mar 26. doi: 10.1002/jlcr.3729. [Epub ahead of print] PMID: 30912586.                                                                                        (IF 1,4).

38.     Koristka, S., Ziller-Walter, P., Arndt, C., Feldmann, A., Kegler, A., Ehninger, A., Cartellieri, M., Ehninger, G., Bornhäuser, M. and Bachmann, M.P. (2019) Anti-CAR engineered T cells for epitope-based elimination of autologous CAR T cells. Cancer Immunol. Immunotherapy  Sep;68(9):1401-1415. doi: 10.1007/s00262-019-02376-y. Epub 2019 Aug 14. PMID: 31414180                                                                                                                                                              (IF 4,2).

39.     Arndt C, Bachmann M, Bergmann R, Berndt N, Feldmann A, Koristka S. (2019). Theranostic CAR T cell Targeting, a brief review. J Labelled Comp Radiopharm. 2019 Mar 19. doi: 10.1002/jlcr.3727. [Epub ahead of print] PMID: 30889625.

                                                                                                                                                                                     (IF 1,4).

40.     Wagner, F., Hölig, U., Wilczkowski, F., Plesca, I., Sommer, U., Wehner, R., Kießler, M., Jarosch, A., Flecke, K., Arsova, M., Tunger, A., Bogner, A., Reißfelder, C., Weitz, J., Schäkel, K., Troost, E.G.C., Krause, M., Folprecht, G., Bornhäuser, M., Bachmann, M.P., Aust, D., Baretton, G. and Schmitz, M. (2019). Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer. Front Immunol. 2019 Mar 29;10:602. doi: 10.3389/fimmu.2019.00602. eCollection 2019. PMID: 30984181.              (IF 5,5).

41.     Bachmann, M. (2019). The UniCAR system: A modular CAR T cell approach to improve the safety of CAR T cells. Immunol. Lett. May 12. pii: S0165-2478(19)30045-8. doi: 10.1016/j.imlet.2019.05.003. [Epub ahead of print] Review. PMID: 31091431                                                                                                                                                        (IF 2,4).

42.     Jureczek, J., Bergmann, R., Berndt, N., Koristka, S., Kegler, A., Puentes-Cala, E., Soto, J.A., Arndt, C., Bachmann, M., and Feldmann, A. (2019). An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells. Scientific Reports Sci Rep. 2019 Jul 22;9(1):10547. doi: 10.1038/s41598-019-47044-4. PMID: 31332252                                                                                                                                 (IF 4,2).

43.     Fasslrinner, F., Arndt, C., Koristka, S., Feldmann, A., Altmann, H., von Bonin, M., Schmitz, M., Bornhäuser, M., and Bachmann, M. (2019). Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid. Br J Haematol. 2019 Sep;186(5):735-740. doi: 10.1111/bjh.15975. Epub 2019 May 23.                (IF 5,1).

44.     Feldmann, A., Arndt, C., Koristka, S., Berndt, N., Bergmann, R. and Bachmann, M. (2019). Conventional CARs versus Modular CARs.  Cancer Immunol. Immunotherapy.     Oct;68(10):1713-1719. doi: 10.1007/s00262-019-02399-5. Epub 2019 Sep 21. Review. PMID: 31542798.                                                                                                                  (IF 4,2).

45.     Arndt, C., Feldmann, A., Koristka, S., Schäfer, M., Bergmann, R., Mitwasi, N., Bachmann, D., Kegler, A., Schmitz, M., Puentes-Cala, E., Soto, J.A., Ehninger, G., Pietzsch, J., Liolios, C., Wunderlich, G., Kotzerke, J., Kopka, K. and Bachmann, M. (2019). A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR. Oncoimmunology. 2019 Sep 7;8(11):1659095. doi: 10.1080/2162402X.2019.1659095. eCollection 2019. PMID: 31646084                                                                                               (IF 5,5).

2018 (IF 47,8)

46.     Albert, S., Ehninger, A., Gerbaulet, A., Cartellieri, M., Arndt, C., Koristka, S., Feldmann, A., Berndt, N., Bergmann, R., Loureiro, L., Boni, M., Ehninger, G., Bornhäuser, M., and Bachmann, M. (2018). Tonic signaling and its effects on lymphopoiesis of CAR-armed hematopoietic stem and progenitor cells. J. Immunol. 2019 Mar 15;202(6):1735-1746. doi: 10.4049/jimmunol.1801004. Epub 2019 Feb 6. PMID: 30728213                                                                 (IF 4,3).

47.     David, T., Hlinová. V., Kubíček, V., Bergmann, R., Striese, F., Berndt, N., Szöllősi, D., Kovács, T., Máthé, D., Bachmann, M., Pietzsch, H.J. and Hermann, P. Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators. J. Med. Chem. 2018 Sep 24. doi: 10.1021/acs.jmedchem.8b00932. [Epub ahead of print]. PMID: 30180567.                                                                                                                                                                                                                                                         (IF 6,3)    

48.     Ullrich, M. Liers, J., Bergmann, R., Peitzsch, M., Feldmann, A., Sommer, U., Richter, S., Bornstein, S.R., Bachmann, M., Eisenhofer, G., Ziegler, C.G. and Pietzsch, J. (2018). Metastatic Spread of Mouse Pheochromocytoma Cells in Allograft Models Featuring Different Immunologic Phenotypes. Endocr Relat Cancer. 2018 Oct 5;25(12):993-1004. doi: 10.1530/ERC-18-0136. PMID: 30288966                                                                                                              (IF 5,3)

49.     Loureiro, L., Feldmann, A., Bergmann, R., Koristka, S., Berndt, N., Arndt, C., Pietzsch, J., Novo, C., Videira, P. and Bachmann, M. (2018). Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells. Blood Cancer J. 2018 Aug 22;8(9):81. doi: 10.1038/s41408-018-0113-4. No abstract available. PMID: 30190468                                                                                                                                                                                   (IF 8,2)

50.     Albert, S., Arndt, C., Koristka, S., Berndt, N., Bergmann, R., Feldmann, A., Schmitz, M., Pietzsch, J., Steinbach, J. and Bachmann, M. (2018). From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo. Oncotarget. 2018 May 22;9(39):25597-25616. doi: 10.18632/oncotarget.25390. eCollection 2018 May 22. PMID: 29876011                                     (IF 5,2).

51.     Kovács N, Szigeti K, Hegedűs N, Horváth I, Veres DS, Bachmann M, Bergmann R, Máthé D. (2018). Multimodal PET/MRI Imaging Results Enable Monitoring the Side Effects of Radiation Therapy. Contrast Media Mol Imaging. 2018 Nov 1;2018:5906471. doi: 10.1155/2018/5906471. eCollection 2018. PMID: 30515069                                      (IF 1,8)

52.     Koristka, S., Kegler, A., Bergmann, R., Arndt, C., Feldmann, A., Albert, S., Cartellieri, M., Ehninger, A., Ehninger, G., Bornhäuser, M., Schmitz, M., Pietzsch, J., Steinbach, J., and Bachmann, M. (2018). Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology. (2018). J Autoimmun. 2018 Jun;90:116-131. doi: 10.1016/j.jaut.2018.02.006. Epub 2018 Mar 2. PMID: 29503042                                                                    (IF 7,6)

53.     Krackhardt, A., Anliker, B., Hildebrandt, M., Bachmann, M., Eichmüller, S.B., Nettelbeck, D., Renner, M., Uharek, L., Willimsky, G., Schmitt, M., Wels, W.S. and Schüssler-Lenz M. (2018). Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the german cancer Consortium approach. Cancer Immunol Immunother. 2018 Apr;67(4):513-523. doi: 10.1007/s00262-018-2119-y. Epub 2018 Jan 29. Review. PMID: 29380009

                                                                                                                                                                                     (IF 4,7)

2017 (IF 60,6)

54.     Huebner, D., Rieger, C., Bergmann, R., Ullrich, M., Meister, S., Toma, M., Wiedemuth, R., Temme, A., Novotny, V., Wirth, M.P., Bachmann, M., Pietzsch, J. and Fuessel, S. (2017). An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment. BMC Cancer. 2017 Nov 23;17(1):790. doi: 10.1186/s12885-017-3778-3. PMID: 29169339.                                     (IF 3,3)

55.     Mitwasi, N., Feldmann, A., Bergmann, R., Berndt, N., Arndt, C., Koristka, S., Kegler, A., Jureczek, J., Hoffmann, A., Ehninger, A., Cartellieri, M., Albert, S., Rossig, C., Ehninger, G., Pietzsch, J., Steinbach, J. and Bachmann, M. (2017). Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells. Oncotarget. 2017 Sep 18;8(65):108584-108603. doi: 10.18632/oncotarget.21017. eCollection 2017 Dec 12. PMID: 29312553                                                                                                                                                                                                    (IF 5,2)

56.     Bachmann, D., Aliperta, R., Bergmann, R., Feldmann, A., Koristka, S., Arndt, C., Loff, S., Welzel, P.B., Albert, S., Kegler, A., Ehninger, A., Cartellieri, M., Ehninger, G., Bornhäuser, M., v.Bonin, M., Werner, C., Pietzsch, J., Steinbach, J. and Bachmann, M.P. (2017). Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19. Oncotarget. 2017 Dec 21;9(7):7487-7500. doi: 10.18632/oncotarget.23556. eCollection 2018 Jan 26. PMID: 29484126                                                                                                                                                                                 (IF 5,2).   

57.     Aliperta, R., Welzel, P.B., Bergmann, R., Freudenberg, U., Berndt, N., Feldmann, A., Arndt, C., Koristka, S., Stanzione, M., Cartellieri, M., Ehninger, A., Ehninger, G., Werner, C., Pietzsch, J., Steinbach, J., Bornhauser, M. and Bachmann, M.P. (2017). Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy. Scientific Reports. Article Number: 42855. DOI: 10.1038/srep42855.                        (IF 5,5).

58.     Albert, S., Arndt, C., Feldmann, A., Bergmann, R., Bachmann, D., Koristka, S., Ludwig, F., Ziller-Walter, P., Kegler, A., Gärtner, S., Schmitz, M., Ehninger, M., Cartellieri, M., Ehninger, G., Pietzsch, H.J., Pietzsch, J., Steinbach, J. and Bachmann, M. (2017). A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform. OncoImmunology, VOL. 0, NO. 0, e1287246 (17 pages) https://doi.org/10.1080/2162402X.2017.1287246.                                                                                  (IF 7,6).

59.     Heidenreich, F., Rücker-Braun, E., Walz, J.S., Eugster ,A., Kühn, D., Dietz, S., Nelde, A., Tunger, A., Wehner, R., Link, C.S., Middeke, J.M., Stölzel, F., Tonn, T., Stevanovic, S., Rammensee, H.G., Bonifacio, E., Bachmann, M., Zeis, M., Ehninger, G., Bornhäuser, M., Schetelig, J. and Schmitz, M. (2017) Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells. Haematologica. 2017 Aug 24. pii: haematol.2017.167312. doi: 10.3324/haematol.2017.167312. [Epub ahead of print] No abstract available. PMID: 28838995.                                                                                                                 (IF 7,7)

60.     Tunger, A., Wehner, R., von Bonin, M., Kühn, D., Heidenreich, F., Matko, S., Nauerth, M., Rücker-Braun, E., Dietz, S., Link, C.S., Eugster, A., Odendahl, M., Busch, D.H., Tonn, T., Bonifacio, E., Germeroth, L., Schetelig, J., Bachmann, M.P., Bornhäuser, M., and Schmitz, M.  (2017). Generation of high-avidity, WT1-reactive CD8+ cytotoxic T cell clones with anti-leukemic activity by streptamer technology. Leuk. Lymphoma. 2017 May;58(5):1246-1249. doi: 10.1080/10428194.2016.1233538. Epub 2016 Nov 16. No abstract available. PMID: 27852136     (IF 3,0).

61.     Feldmann, A., Arndt, C., Bergmann, R., Loff, S., Cartellieri, M., Bachmann, D., Aliperta, R., Hetzenecker, M., Ludwig, F., Albert, S., Ziller-Walter, P., Kegler, A., Koristka, S., Gärtner, S., Schmitz, M., Ehninger, A., Ehninger, G., Pietzsch, J., Steinbach, J. and Bachmann, M. (2017). Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”. Oncotarget · February 2017. 31368-31385.  DOI: 10.18632/oncotarget.15572.                                                                                        (IF 5,2).

62.     Pfannkuchen, N., Meckel, N., Bergmann, R., Bachmann, M. and Rösch, F. (2017). Radiolabeled bisphosphonates for PET diagnosis and endoradiotherapy of bone metastases. Pharmaceuticals. May 18;10(2). pii: E45. doi: 10.3390/ph10020045. PMID: 28524118

63.     Bergmann, R., Splith, K., Pietzsch, J., Bachmann, M. and Neundorf, I. (2017). Biological characterization of novel nitroimidazole-peptide conjugates in vitro and in vivo: Nitroimidazole-peptide Conjugates. Journal of Peptide Science March 2017.  DOI: 10.1002/psc.2995.

64.     Link, T., Kuithan, F., Ehninger, A., Kuhlmann, J.D., Kramer, M., Werner, A., Gatzweiler, A., Richter, B., Ehninger,  G., Baretton, G., Bachmann, M., Wimberger, P. and Friedrich, K. (2017). Exploratory investigation of PSCA protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression". Oncotarget Apr 29. doi: 10.18632/oncotarget.17523. [Epub ahead of print] PMID: 28512267.                                                                      (IF 5,2).

65.     Bejestani, E.P., Cartellieri, M., Ehninger, A., Loff, S., Spehr, J., Bergmann, R., Dietrich, A., Feldmann, A., Albert, S., Wermke, M., Baumann, M., Krause, M., Bornhäuser, M., Ehninger, G., Bachmann, M. and von Bonin, M. (2017). Pre-clinical characterization of a switchable Chimeric Antigen Receptor platform to target solid neoplasms. Oncoimmunology. 2017 Jun 20;6(10):e1342909. doi: 10.1080/2162402X.2017.1342909. eCollection 2017. PMID: 29123951                                                                                                                                                                                                  (IF 7,6).

66.     Bergmann, R., Kubeil, M., Zarschler, K., Sandeep, C., Tajhya, R.B., Beeton, C., Pennington, M.W., Bachmann, M., Norton, R.S. and Stephan, H. (2017). Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats. Scientific Reports Jun 16;7(1):3756. doi: 10.1038/s41598-017-03998-x. PMID: 28623364                                                                                                                                                                                                                          (IF 5,5).

2016 (IF 20,0)

67.     Cartellieri, M., Feldmann, A., Koristka, S., Arndt, C., Loff, S., Ehninger, A., von Bonin, M., Bejestani, E.P., Ehninger, G., and Bachmann, M.P. (2016). Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts. Blood Cancer J. 2016 Aug 12;6(8):e458. doi: 10.1038/bcj.2016.61. PMID: 27518241.                   (IF 8,2).

68.     Ullrich, M., Bergmann, R., Peitzsch, M., Zenker, E.F., Cartellieri, M., Bachmann, M., Ehrhart-Bornstein, M., Block, N.L., Schally, A.V., Eisenhofer, G., Bornstein, S.R., Pietzsch, J., and Ziegler, C.G. (2016). Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model. Theranostics. 2016 Mar 10;6(5):650-65. doi: 10.7150/thno.14479. eCollection 2016 Mar 10. PMID: 27022413.

                                                                                                                                                                                     (IF 8,9).

69.     Langosch, S., Wehner, R., Malecka, A., Franks, H.A., Schäkel, K., Bachmann, M., Jackson, A.M. and Schmitz, M.  (2016). Impact of p38 mitogen-activated protein kinase inhibition on immunostimulatory properties of human 6-sulfo LacNAc dendritic cells. Immunobiology. 2016 Feb;221(2):166-74. doi: 10.1016/j.imbio.2015.09.012. Epub 2015 Sep 10. PMID: 26391152                                                                                                                                                                (IF 2,9).

2015 (IF 24,6)

70.     Koristka, S., Cartellieri, M., Arndt, C., Feldmann, A., Seliger, B., Ehninger, G. and Bachmann, M.P. (2015). Tregs activated by bispecific antibodies: Killers or suppressors? OncoImmunology. 2015 Jan 23;4(3):e994441. eCollection 2015 Jan 23. PMID: 25949920                                                                                                                                                 (IF 7,6). 

71.     Aliperta, R., Cartellieri, M., Feldmann, A., Arndt, C., Koristka, S., Michalk, I., von Bonin, M., Ehninger, A., Bachmann, J., Ehninger, G., Bornhäuser, M. and Bachmann, M.P. (2015). Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts. Blood Cancer J. 2015 Sep 18;5:e348. doi: 10.1038/bcj.2015.73. PMID: 26383821                                                                                                              (IF 4,4).

72.     Töpfer, K., Cartellieri, M., Michen, S., Wiedemuth, R., Müller, N., Lindemann, D., Bachmann, M., Füssel, M., Schackert, G. and Temme, A. (2015). DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy. J. Immunol. 2015 Apr 1;194(7):3201-12. doi: 10.4049/jimmunol.1400330. Epub 2015 Mar 4. PMID: 25740942

                                                                                                                                                                                     (IF 5,0).

73.     Toma, M., Wehner, R., Kloß, A., Hübner, L., Fodelianaki, G., Erdmann, K., Füssel, S., Zastrow, S., Meinhardt, M., Seliger, B., Brech, D., Noessner, E., Tonn, T., Schäkel, K., Bornhäuser, M., Bachmann, M.P., Wirth, M.P., Baretton, G. and Schmitz M. (2015). Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis. OncoImmunology. 2015 Mar 2;4(6):e1008342. eCollection 2015 Mar 2. PMID: 26155414.                                                                                                                                                                                            (IF 7,6).

74.     Bartsch, H. and Bachmann, M.P. (2015). Sequential Use of Immunoblots for Characterization of Autoantibody Specificities. Methods Mol Biol. 2015;1314:173-8. doi: 10.1007/978-1-4939-2718-0_18. PMID: 26139265

75.     Bartsch, H. Franke, C. and Bachmann, M.P. (2015). Immunoblotting Using Radiolabeled Reagents for Detection. Methods Mol Biol. 2015;1314:73-8. doi: 10.1007/978-1-4939-2718-0_9. PMID: 26139256

76.     Franke, C., Gräfe, D., Bartsch, H., and Bachmann M.P. (2015). Use of Nonradioactive Detection Method for North- and South-Western Blot. Methods Mol Biol. 2015;1314:63-71. doi: 10.1007/978-1-4939-2718-0_8. PMID: 26139255

77.     Canzler, U., Bartsch, H., Großmann, K., Lehmann, W., Conrad, K., Kurien, B.T., Dorri, Y., Scofield, R.H. and Bachmann, M.P. (2015). A miniaturized blotting system for simultaneous detection of different autoantibodies. Methods Mol Biol. 2015;1312:165-73. doi: 10.1007/978-1-4939-2694-7_20. PMID: 26044001

2014     (IF 64,9)

78.     Arndt, C., Feldmann, A., von Bonin, M., Cartellieri, M., Ewen, E.-M., Koristka, S., Michalk, I., Stamova, S., Berndt, N., Hermsdorf, A., Bornhäuser, M., Ehninger, G., Schmitz, M. and Bachmann, M. (2014). Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: Description of a novel modular targeting system. Leukemia 28, 59-69. doi: 10.1038/leu.2013.243. [Epub 2013 Aug 20]                                                       (IF 10,2). 

79.     Chatzigeorgiou, A., Chung, K.-J., Garcia-Martin, R., Alexaki, I., Klotzsche-von Ameln, A., Phieler, J., Sprott, D., Kanczkowski, W., Tzanavari, T., Bdeir, M., Bergmann, S., Cartellieri, M., Bachmann, M., Nikolakopoulou, P., Androutsellis-Theotokis, A., Siegert, G., Bornstein, S. R., Muders, M.H., Boon, L., Karalis, K.P., Lutgens, E. and Chavakis, T. (2014). Dual role of B7 costimulation in obesity-related non-alcoholic steatohepatitis (NASH) and metabolic dysregulation. Hepatology,in press.                                                                                                                                                                      (IF12,0).  

80.     Töpfer, K., Cartellieri, M., Angermann, S., Müller, N., Lindemann, D., Bachmann, M., Schackert, G. and  Temme, A. (2014). DAP12-based activating chimeric antigen receptor for Natural Killer cell tumor immunotherapy. J. Immunol. In press.                                                                                                                                                                                                                     (IF 5,5).

81.     Cartellieri, M., Arndt, C., Feldmann, A., von Bonin, M., Ewen, E., Koristka, S., Michalk, I., Stamova, S., Berndt, N., Gocht, A., Bornhäuser, M., Ehninger, G., Schmitz, M. and Bachmann, M. (2014). TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity. OncoImmunology 2013; 2:e26770.

(IF 6,6)

82.     Koristka, S., Cartellieri, M., Arndt, C., Feldmann, A., Töpfer, K., Michalk, I., Temme, A., Ehninger, G. and Bachmann, M. (2014). Cytotoxic response of human regulatory T cells upon T cell receptor-mediated activation – a matter of purity. B. C. J. In press.                                                                                                                                                                              (IF 2,9).   

83.     Ehninger, A., Kramer, M., Röllig, C., Thiede, C., Bornhauser, M., von Bonin, M., Wermke, M., Feldmann, A., Bachmann, M., Ehninger, G. and Oelschlägel, U. (2014). Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia. B. C. J. In press.                                                                                                                            (IF 2,9).

84.     Cartellieri, M., Koristka, S., Arndt, C., Feldmann, A., Stamova, S., v. Bonin, M.,Töpfer, K., Krüger, T., Geib, M., Michalk, I., Temme, A., Bornhäuser, M., Lindemann, D., Ehninger, G. and Bachmann, M. P. (2014). A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PloS One 2014 Apr 3;9(4):e93745. doi: 10.1371/journal.pone.0093745.                                                                                                                        (IF 3,73).

85.     Michalk, I., Feldmann, A., Koristka, S., Arndt, C., Cartellieri, M., Ehninger, A., Ehninger, G. and Bachmann, M. P. (2014). Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8. PloS One 2014 Apr 21;9(4):e95517. doi: 10.1371/journal.pone.0095517.                                                  (IF 3,73).

86.     Sommer, U., Larsson, B., Tuve, S., Wehner, R., Zimmermann, N., Kramer, M., Kloß, A., Günther, C., Babatz, J., Schmelz, R., Brückner, S., Schetelig, J., Bornhäuser, M., Schäkel, K., Bachmann, M.P, Aust, D., Barretton, G. and Schmitz, M. (2014). Proinflammatory human 6-sulfo LacNAc+ dendritic cells accumulate in intestinal acute graft-versus-host disease. Haematologica. 2014 Mar 28. [Epub ahead of print]. PMID:24682513.                                                              (IF 5,93).

87.     Wölbing, P., Maas, M., Döbel, T., Öhrl, S., Enk, A.H., Bachmann, M. and Schäkel, K., (2014). Generation of the monoclonal antibody DD3 and its unique specificity for a subset of human CD16+monocytes/dendritic cells. Exp. Dermatol. 23, in press.                                                                                                                                                                                      (IF 3,6).

88.     Arndt, C., Feldmann, A., Töpfer, K., Koristka, S., Cartellieri, M., Temme, A., Ehninger, A., Ehninger, G. and Bachmann, M. (2014). Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells. Prostate, in press.                                                                                        (IF 3,84).

89.     Arndt, C., Feldmann, A., Koristka, S., Cartellieri, M., Dimmel, M., Ehninger, A., Ehninger, G. and Bachmann, M. (2014). Simultaneous Targeting of Prostate Stem Cell Antigen and Prostate-Specific Membrane Antigen Improves the Killing of Prostate Cancer Cells Using a Novel Modular T Cell-Retargeting System. Prostate, in press.                                  (IF 3,84).

2013 (IF 68,4)

90.     Arndt, C., von Bonin, M., Cartellieri, M., Feldmann, A., Koristka, S., Michalk, I., Stamova, S., Bornhäuser, M., Ehninger, G. and Bachmann, M. (2013). Redirection of T cells with a first fully humanized bispecific CD33-CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells. Leukemia, doi: 10.1038/leu.2013.18. [Epub ahead of print]                                                                                                                                                                                          (IF 10,2). 

91.     Koristka, S.,  Cartellieri, M., Arndt, C., Bippes, C.C., Feldmann, A., Michalk, I., Wiefel, K., Stamova, S., Schmitz, M., Ehninger, G., Bornhäuser, M. and Bachmann, M. (2013). The nuclear antigeen La: An inducible target for retargeting of human regulatory T cells for the treatment of GvHD? J. Autoimmunity 42, 105-16. DOI: 10.1016/j.jaut.2013.01.002   (Epub 2013 Jan 22)                                                                                                                                                                     (IP 7,4).   

92.     Thieme, S., Gyárfás, T., Richter, C., Özhan-Kizil, G., Fu, J., Alexopoulou, D., Muders, M.H., Michalk, I., Jakob, C., Dahl, A., Klink, B., Bandoła, J., Bachmann, M., Schröck, E., Buchholz, F., Stewart, A.F., Weidinger, G., Anastassiadis, K. and Brenner, S. (2013). The histone demethylase UTX regulates stem cell migration and hematopoiesis. Blood, 121, 2462-2473   DOI: 10.1182/blood-2012-08-452003. (Epub 2013 Jan 30)                                                                           (IF 9,9).

93.     Wehner, R., Taubert, C., Mende, T., Gaebler, C., Gouveia de Andrade, A.V., Bornhäuser, M., Werner, C., Tonn, T., Schäkel, K., Bachmann, M. and Schmitz, M. (2013). Engineered extracellular matrix components do not alter the immunomodulatory properties of mesenchymal stromal cells in vitro. J. Tissue Eng. Regen. Med. doi: 10.1002/term.1500. [Epub ahead of print]                                                                                                                                                                                   (IF 3,3).

94.     Jähnisch, H., Wehner, R., Tunger, A., Kunze, A., Oehrl, S., Schäkel, K., Rohayem, J., Bornhäuser, M., Tonn, T., Bachmann, M. and Schmitz, M. (2013). TLR7/8 agonists trigger immunostimulatory properties of human 6-sulfo LacNAc dendritic cells. Cancer Lett. DOI: 10.1016/j.canlet.2013.02.003 (Epub 2013 Feb 09).                                           (                IF 4,2).

95.     Kloss C. C., Condomines, M., Cartellieri, M., Bachmann, M. and Sadelain, M. (2013). Combinatorial antigen-recognition with balanced signaling ensures selective tumor eradication by engineered T cells. Nature Biotechnology, doi:10.1038/nbt.2459.                                                                                                                                                 (IF 32,44).


2012 (IF 29,8)

96.     Feldmann, A., Arndt, C., Töpfer, K., Stamova, S., Krone, F., Cartellieri, M., Koristka, S., Michalk, I., Lindemann, D., Schmitz, M., Temme, A., Bornhäuser, M., Ehninger, G. and Bachmann, M. (2012). Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T Cells. J. Immunol. 15;189(6):3249-59. Doi: 10.4049/jimmunol.1200341. Epub 2012 Aug 8.                                                                   (IF 5,7).

97.     Wehner, R., Bitterlich, A., Meyer, N., Kloß, A., Schäkel, K., Bachmann, M., and Schmitz, M. (2012). Impact of chemotherapeutic agents on the immunostimulatory properties of human 6-sulfo LacNAc+ (slan) dendritic cells. Internat. J. Cancer. Doi: 10.1002/ijc.27786. [Epub ahead of print].                                                                                                       (IF 5,4).

98.     Hänsel, A., Günther, C., Döbel,T., Baran, W., Schmitz, M., Bachmann, M. and Schäkel, K. (2012). TLR7 and TLR8 expressing slan (6-sulfo LacNAc) dendritic cells as a novel proinflammatory cell type in Lupus erythematosus. J. Autoimmunity 40,1-8.   DOI: 10.1016/j.jaut.2012.07.005   Published: FEB 2013 PMID: 22890025.         (IF 7,4).

99.     Kurien, B., Dorri, Y., Bachmann, M. and Scofield, R.H. (2012). Induction of anti-Ro 60/anti-La by immunization with spectrin and, induction of anti-spectrin by immunization with Ro60 and 4-hydroxy 2-nonenal-modified Ro 60 immunization In press. Clinical and Experimental. Rheumatol. 30, 886-893                                                                                               (IF 2,4).

100.   Wehner, R., Taubert, C., Mende, T., Gaebler, C., Andrade, A. V. G., Bornhäuser, M., Werner, C., Tonn, T., Schäkel, K.,  Bachmann, M. and Schmitz, M. (2012). Engineered extracellular matrix components do not alter the immunomodulatory properties of mesenchymal stromal cells in vitro. J. Tissue eng. regen. Doi: 10.1002/term.1500. [Epub ahead of print].

(IF 3,5).

101.   Stamova, S., Feldmann, A., Cartellieri, M., Wehner, R., Schmitz, M., Bornhäuser, M., von Bonin, M., Ehninger, G., Bartsch, H. and Bachmann, M. (2012). Single-chain-bispecific anti-CD3-anti-CD33 GFP-fusion antibody constructs for in vivo analysis. Anal. Biochem. 423, 261-268.                                                                                                                     (IF 3,2).

102.   Koristka, S.,  Cartellieri, M., Theil, A., Feldmann, A., Arndt,C., Stamova, S., Michalk, I., Kretschmer, K., Bornhäuser, M., Ehninger, G., Schmitz, M. and Bachmann, M. (2012). Retargeting of human regulatory T cells by single chain bispecific antibodies. J. Immunol. 188, 1551-1558.                                                                                                                             (IF 5,7).

2011 (IF 53,4)

103.   Stamova, S., Cartellieri, M., Feldmann, A., Bippes, C.C., Bartsch, H., Wehner, R., Schmitz, M., von Bonin, M., Bornhäuser, M., Ehninger, G, Rieber, E.P. and Bachmann, M. (2011). Novel bispecific antibody constructs for redirecting of T- and NK-cells to AML-Blasts. Leukemia 25 1053-1056.                                                                                           (IF 9,6).

104.   Stamova, S., Cartellieri, M., Feldmann, A., Arndt, C., Koristka, S., Bartsch, H., Bippes, C.C., Wehner, R., Schmitz, M., von Bonin, M., Bornhäuser, M., Ehninger, G. and Bachmann, M. (2011). Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module. Mol. Immunol. 49, 474-482.

(IF 2,9).

105.   Bippes, C.C., Feldmann, A., Stamova, S., Cartellieri, M., Schwarzer, A., M., Wehner, R., Schmitz, M., Rieber, E.P., Zhao, S., Schäkel; K.,  Temme, A., R. Scofield, R.H., Kurien, B., Bartsch, H. and Bachmann, M. (2011). A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs), PLoS ONE  2011 Jan 21;6(1):e16315.                                                                                                                                           (IF 4,4).

106.   Feldmann, A., Stamova, S., Bippes, C.C., Bartsch, H., Wehner, R., Schmitz, M., Temme, A., Cartellieri, M. and Bachmann, M. (2011). Redirection of T cells to Prostate Stem Cell Antigen expressing tumor cells: Comparison of different antibody formats. Prostate 71, 998-1011.                                                                                                                                         (IF 3,4).

107.   Töpfer, K., Kempe, S, Müller, N., Schmitz, M., Bachmann, M., Cartellieri, M., Schackert, G. and Temme, A. (2011). Tumor evasion from T cell surveillance. J. Biomed. Biotechnol. Article ID 918471 doi:10.1155/2011/918471.


108.   Bornhäuser, M., Thiede, C., Platzbecker, U., Kiani, A., Oelschlaegel, U., Babatz, J., Lehmann, D., Hölig, K., Radke, J., Tuve, S., Wermke, M., Wehner, R., Jähnisch, H., Bachmann, M., Rieber, E.P., Schetelig, J., Ehninger, G. and Schmitz, M. (2011). Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T-cell -depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia. Blood 117, 7174-84.                                                                                                                                                                                                                        (                        IF 10,6).

109.   Wehner, R., Dietze, K., Bachmann, M. and Schmitz, M. (2011). The bidirectional Crosstalk between Human Dendritic Cells and Natural Killer Cells. J. Innate Immun. 3, 258-263.                                                                                             (IF 4,2).

110.   Hänsel, A., Günther, C., Ingwersen, J., Starke, J., Schmitz, M., Bachmann, M., Rieber, E.P., Meurer, M. and Schäkel, K. (2011). 6-sulfo LacNAc+ dendritic cells are powerful inducers of TH17/Th1 T cells and prevail among inflammatory dermal dendritic cells in psoriatic skin. J. Allergy Clin. Immunol. 127, 787-794.                              .                                  (IF 11,0).

111.   Kurien, B., Porter, A., Dorri, Y., Iqbal, S., D‘Souza, A., Singh, A., Asfa, S., Cartellieri, M., Matsumoto, H., Bachmann, M., Hensley, K. and Scofield, R.H. (2011). Degree of modification of Ro60 by the lipid peroxidation  by-product 4-hydroxy-2-nonenal may differentially induce Sjögren's syndrome or systemic lupus erythematosus in BALB/c mice: Free Rad. Biol. & Med. 50, 1222-1233.                                                                                                                                              (IF 6,1).

2010 (IF 19,9)

112.   Wehner, R., Schumacher, P., Bornhäuser, M., Ehninger, G., Schäkel, K.,  Bachmann, M. and Schmitz, M. (2010). Acute myeloid leukemia cells fail to activate native human dendritic cells: a potential mechanism of immune evasion. Leukemia, 2010 Nov;24(11), 1965-1967. Epub 2010 Sep 2.                                                                                               (IF 8,3).

113.   Zhao, S., Wehner, R., Bornhäuser, M., Wassmuth, R., Bachmann, M. and Schmitz, M. (2010). Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev. 19, 607-614.                                                                                                                                                                         (IF 4,2).

114.   Brenner, C., Kniep, B., Maillier, E., Martel, C., Franke, C., Röber, N., Bachmann, M., Rieber, E.P. and Sandhoff, R. (2010). GD3-7-aldehyde is an apoptosis inducer and interacts with adenine nucleotide translocase. Biochem. Biophys. Res. Commun. 391, 248-253.                                                                                                                              (IF 2,6).

115.   Cartellieri, M., Bachmann, M., Feldmann, A., Bippes, C., Stamova, S., Wehner, R., Temme, A. and Schmitz, M. (2010). Chimeric antigen receptor-engineered T cells for immunotherapy of cancer. J. Biomed. Biotechnol. Epub 2010 May 5.                                                                                                                                                                                                        (IF 1,8).

116.   Jähnisch, H., Füssel, S., Kiessling, A., Wehner, R., Zastrow, S., Bachmann, M., Rieber, E.P., Wirth, M.P. and Schmitz, M. (2010). Dendritic cell-based immunotherapy for prostate cancer. Clin. Dev. Immunol. 2010, 517493. Epub 2010 Nov 4.                                                                                                                                                                                           (IF 3,0).

2009 (IF 16,7)

117.   Wehner, R., Wehrum, D., Bornhäuser, M., Zhao, S., Schäkel, K., Bachmann, M.P., Platzbecker, U., Ehninger, G., Rieber, E.P. and Schmitz, M. (2009). Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells. Haematologica 94, 1151-1156.                                                                                                       (IF 6,4).

118.   Canzler, U., Bartsch, H., Ulitzsch, S., Kurien, B.T., Dorri, Y., Scofield, R.H., Grossmann, K., Lehmann, W., Pilarsky, C., Denz, A., Grützmann, R., Conrad, K., Schmitz, M., Rieber, E.P., Distler, W. and Bachmann, M.P. (2009). Detection of autoantibodies to tumour-associated antigens in sera of patients with systemic autoimmunity using a novel protein microblot array. Scand. J. Immunol. 69, 563-569.                                                                                                             (IF 2,1).

119.   Gerner, M., Hölig, K., Wehner, R., Zhao, S., Schäkel, K., Bachmann, M.P., Rieber, E.P., Bornhäuser, M. and Schmitz M. (2009). Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells. Transplantation 87, 8, 1134-1139.                                                                                                                            (IF 3,5).

120.   Wehner, R., Löbel, B.,  Bornhäuser, M., Schäkel, K., Cartellieri, M., Bachmann, M., Rieber, E.P. and Schmitz, M. (2009). Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells. Internat. J. Cancer 124, 358-366.                                                                                                                                                                                                     (IF 4,7).   

2008 (IF 7,7)

121.   Kiessling, A., Füssel, S., Wehner, R., Bachmann, M., Wirth, M.P., Rieber, E.P and  Schmitz, M. (2008). Advances in specific immunotherapy for prostate cancer.  Eur. Urol.  53, 694-708.                                                                              (IF 7,7).

2007 (IF 33,9)

122.   Dudek, N.L., Maier, S.M., Chen, Z., Mudd, P.A., Mannering, S.I., Jackson, D.C., Zeng, W., Cavill, D., Keech, C.L., Hamlin, K., Pan, Z., Davis-Schwarz, K., Workman-Azbill, J., Bachmann, M., Gordon, T.P., McCluskey J. and Farris, A.D. (2007). T cell epitopes of the La/SS-B autoantigen in humanized transgenic mice expressing the HLA class II haplotype DRB1*0301/DQB1*201. Arthritis Rheum. 56, 3387-3398                                                                         (IF 7,3).

123.   Semsei, I., Maier, S., Workman-Azbill, J., Urban, L., Moser, K., Zeher, M., Bachmann, M. and Farris, A.D. (2007). Detection of a rare oligo(A) repeat tract mutation (8As-->7As) in the sequence encoding the La/SS-B autoantigen. Anal. Biochem. 370, 47-53.                                                                                                                                                                  (IF 3,3).

124.   Straube, C., Wehner, R., Wendisch, M., Bornhäuser, M., Bachmann, M., Rieber, E.P. and Schmitz, M. (2007). Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells.  Leukemia 21, 1464-1471.                                                                                                                                                                                             (IF 8,3).

125.   Morgenroth, A., Cartellieri, M., Schmitz, M., Günes, S., Weigle, B., Bachmann, M., Abken, H., Rieber, E.P. and Temme, A. (2007). Targeting of tumor cells expressing the prostate stem cell antigen (PSCA). Prostate 67, 1121-1131.                                                                                                                                                                                                    (IF 3,3).

126.   Schmitz, M., Temme, A., Senner, V., Ebner, E., Schwind, S., Stevanovic, S., Wehner, R., Schackert, G., Schackert, H.K., Füssel, M., Bachmann, M., Rieber, E.P. and Weigle, B. (2007). Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br. J. Cancer 96, 1293-1301.                                             (IF 4,3).

127.   Schmitz, M., Wehner, R., Stevanovic, S., Kiessling, A., Rieger, M.A., Temme, A., Bachmann, M.,  Rieber, E.P. and Weigle, B. (2007). Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11. Cancer Lett. 24, 331-336.                                                                                                                                 (                 IF 3,7).    

128.   Temme, A., Rodriguez, J.A., Hendruschk, S., Gunes, S., Weigle, B., Schäkel, K., Schmitz, M., Bachmann, M., Schackert, G. and Rieber, E.P. (2007).  Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax. Cancer Lett. 250, 177-193.                                                                                                        (IF 3,7).

2006 (IF 27,7)

129.   Kurien B.T., Hensley, K., Bachmann, M. and Scofield, R.H. (2006). Oxidatively modified autoantigens in autoimmune diseases. Free Rad. Biol. & Med. 41, 549-556.                                                                                (IF 6,1).

130.   Wehner R., Wendisch M., Schäkel, K., Bornhäuser, M., Platzbecker, U., Mohr, B., Temme, A., Bachmann, M., Rieber, E.P. and Schmitz, M. (2006). Imatinib mesylate does not impair the immunogenecity of human myeloid blood dendritic cells. Leukemia 20, 1629-1632.                                                                                                                             (IF 8,3).

131.   Bachmann, M., Bartsch, H., Gross, J.A., Maier, S.M., Gross, T., Workman, J., James, J.A., Harley, J.B.H., Conrad, K., Schmitz, M., Jung, B., Buyon, J.P., Semsei, I., Farris, A.D., Harley, J.B. and Rieber, E.P. (2006). Autoimmunity as the result of escape from RNA surveillance.  J. Immunol.  177, 1698-1707.                                                         (IF 5,6).   

132.   Pan, Z., Davis, K., Maier, S.M., Bachmann, M., Kim-Howard, X.R., Keech, C., Gordon, T., McCluskey J. and Farris, D. (2006). Syngeneic cells in late apoptosis mature DC in vivo and induce antibodies to dsDNA and neo-epitopes of La/SS-B in immunized mice. Clin. Exp. Immunol., 143, 237-248.                                                                                      (IF 3,0).

133.   Schmitz, M., Kiessling, A., Weigle, B., Füssel, S, Meye, A., Wehner, R., Temme, A., Wirth, M.P., Bachmann, M. and Rieber, E.P. (2006). T-cell based strategies for immunotherapy of prostate cancer. Cancer Therapy 3, 565-578.

134.   Kniep, B., Kniep, E., Özkur, N., Bachmann, M., Schulze, A., Malisan, F., Testi, R. and Rieber, E.P. (2006). 9-O-Acetyl GD3 protects tumor cells from apoptosis. Int. J. Cancer, 119, 67-73.                                                                           (IF 4,7).

2005 (IF 28,6)

135.   Schmitz, M., Zhao, S., Deuse, Y., Schäkel, K., Wöhner, H., Hölig, K., Wienforth, F., Kiessling, A., Bornhäuser, M., Temme, A., Rieger, M.A., Weigle, B., Bachmann, M. and Rieber, E.P. (2005). Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity. J. Immunol., 174, 4127-4134.                                                                                                                                                                                                               (IF 5,6).

136.   Scofield H.R., Kurien, B.T., Ganick, S., McClain, M.T., Pye, Q., James, J.A., Schneider, R.I., Broyles, R.H., Bachmann, M. and Hensley, K. (2005). Modification of Lupus-associated 60 kDa Ro protein with the lipid oxidation product 4-Hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radical Biol. &  Med., 38, 719-728.                                                                                                                                                                                                      (IF 6,1).

137.   Cunha, A.C., Weigle, B., Kiessling, A., Bachmann, M. and Rieber, E.P. (2005). Tissue specificity of prostate specific antigens: Comparative analysis of transcript levels in prostate and non-prostatic-tissues. Cancer Lett 236, 229-238.                                                                                                                                                                                                  (IF 3,7).

138.   Füssel, S., Weigle, B., Schmidt, U., Baretton, G., Koch, R., Bachmann, M., Rieber, E.P., Wirth, M.P. and Meye A. (2005). Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairs. Cancer Lett. 236, 95-104.                                                                                                                                                           (IF 3,7).

139.   Conrad, K., Bachmann, M., Matsuura, E. and Shoenfeld, Y. From animal models to human genetics: Research on the pathogenicity of autoantibodies. (2005). Autoimmunity Rev., 4, 178-187.                                                   (IF 6,4).

140.   Kiessling, A., Weigle, B., Fuessel, Ebner, R., Rieger, M.A., Schmitz, M., Temme, A., Bachmann, M., Meye, A., Wirt, M.P. and Rieber E.P. (2005). D-TMPP: a novel androgen-regulated gene preferentailly expressed in prostate and prostate cancer that encodes a putative transmembrane protein and is the first characterised member of a eukaryotic gene family. Prostate, 64, 387-400.                                                                                                                                                        (IF 3,1).

2004 (IF 9,9)

141.   Kurien B.T., Pillow, B.W.,  Dori, Y., Hensley, K., Bachmann, M. and Scofield, R.H. (2004). SOD1 interacts directly with hemoglobin in vitro. Thromb. Haemost.  92, 218-220.                                                                                    (IF 3,0).

142.   Weigle, B., Fuessel, S., Ebner, R., Temme, A., Schmitz, M., Schwind, S., Kiessling, A., Rieger, M.A., Meye, A., Bachmann, M., Wirth, M.P. and Rieber, E.P. (2004). D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate. Biochem. Biophys. Res. Com. 322, 239-249.                                                                 (IF 2,6).   

143.   Scofield, R.H., Kurien, B.T., Gross J.A., Reed, N.B., Taylor A.K., Dominguez, N. and Bachmann, M. (2004). Interaction of calcium and Ro60: Increase of antigenicity. Mol. Immunol. 41, 809-816.                                              (IF 4,3).

2003 (IF 2,0)

144.   Nakken, B., Pan, Z., Bachmann, M. and Farris, D. (2003). T-Helper cell tolerance to ubiquitous nuclear antigens. Scand. J. Immunology 58, 478-492.                                                                                                                            (IF 2,0).

2001 (IF 3,2)

145.   Scofield, R. H., Kurien, B. T., Yhang, F., Mehta, P., Kaufman, K., Gross, T., Bachmann, M., Gordon, T., and Harley, J. B. (2001). Protein-protein interaction of the Ro ribonucleoprotein particle using multiple antigenic peptides. Mol.  Immunol. 36, 1093-1106.                                                                                                                                                                          (IF 3,2).

2000 (IF 26,2)

146.   Semsei, I., Zeher, M., Takcs, I., Urban, L., Szegedi, G. and Bachmann, M. (2000). High frequency of t(14:18) translocation in Sjögren’s syndrome. Arthritis Rheum. 43, 951-952.                                                                                              (IF 7,3).

147.   Blaheta, R.A., Hailer, N.P., Brude, N., Wittig, B., Leckel, K., Oppermann, E., Bachmann, M., Harder, S., Cinatl, J., Scholz, M., Bereiter-Hahn, J., Weber, S., Encke, A. and Markus, B.H. (2000). In vitro analysis of verapamil-induced immunosuppression: potent inhibition of T cell motility and lymphocytic transmigration through allogeneic endothelial cells. Transplantation. 69, 588-97.                                                                                                                                 (IF 3,5).

148.   Weser, S., Bachmann, M., Seifart K. H. and Meißner, S. (2000). Efficiency of human pol III genes in vitro does not depend on the RNP-forming autoantigen La.  Nucl. Acids. Res., 28, 3935-42.                                                 (IF 7,5).

149.   Takacs, I., Zeher, M., Urban, L., Bachmann,  M., Szegedi, G. and Semsei, I. (2000). Frequency and evaluation of t(14;18) translocation in Sjögren's syndrome. Ann. Hematol., 79, 444-448.                                                        (IF 2,2).

150.   Pfeuffer, T., Goebel, W., Laubinger, J., Bachmann, M.  and Kuhn, M. (2000). LaXp180, a mammalian ActA-binding protein, identified with the yeast two-hybrid system, colocalizes with intracellular Listeria monocytogenes. Cell Microbiology. 2, 101-114.                                                                                                                                                                               (IF 5,7).

1999 (IF 16,3)

151.   Blaukat, A., Herzer, K., Schroeder, C., Bachmann, M., Nash, N. and Müller-Esterl, W. (1999). Overexpression and functional characterization of kinin receptors reveal subtype-specific phosphorylation. Biochemistry 38, 1300-1309.                                                                                                                                                                                                                 (IF 3,2).

152.   Azzarolo, A.M., Wood, R.L., Mircheff, A.K., Richters, A., Olsen, E., Huang, Z.M., Berkowitz, M., Bachmann, M.,  Zolfagari, R. and Warren, W. (1999). Androgen modulation of lacrimal gland interstitial cell apoptosis and infiltration.  Invest. Ophthalmol. Vis. Sci. 40, 592-602.                                                                                                              (IF 3,4).

153.   Yang, T., Zeng, H., .Zhang, J., Okamoto, C. T., Warren, D. W., Wood, R. L., Bachmann, M. and Mircheff, A. K. (1999). Major histocompatibility complex class II molecules, cathepsins, and La/SSB proteins in lacrimal acinar cell endomembranes. Am. J.  Physiol.  277, 994-1007.                                                                                                                                  (IF 4,0).

154.   Scofield, R. H., Kurien, B. T., Yhang, F., Mehta, P., Kaufman, K., Gross, T., Bachmann, M., Gordon, T., and Harley, J. B. (1999). Protein-protein interaction of the Ro ribonucleoprotein particle using multiple antigenic peptides. Mol. Immunol. 36, 1093-1106.                                                                                                                                                                          (IF 3,2).

155.   Yang, T., Zeng, H., .Zhang, J., Okamoto, C. T., Warren, D. W., Wood, R. L., Bachmann, M. and Mircheff, A. K. (1999). Stimulation with carbachol alters endomembrane distribution and plasma membrane of intracellular proteins in lacrimal acinar cells. Exp. Eye Res. 69, 651-661.                                                                                                                         (IF 2,5).

1998 (IF 27,1)

156.   Dedio, J., Jahnen-Dechent, W., Bachmann, M. and Müller-Esterl, W. (1998). The multiligand binding protein gC1qR, putative C1q receptor is targeted to mitochondria. J. Immunol. 160, 3534-3542.                                                              (IF 5,6).

157.   Bachmann, M., Deister, H., Schmitz, M., Pautz, A., Laubinger, J., Falke, D., Podlech, J. and Grölz, D. (1998). The human nuclear autoantigen La/SS-B accelerates herpes simplex virus type 1 replication in transfected mouse cells. Clin. Exp. Immunol. 112, 482-489.                                                                                                                                                (IF 3,0).

158.   Kremerskothen, J., Nettermann, M., op de Bekke, A., Bachmann, M. and Brosius, J. (1998). Identification of the autoantigen La/SS-B as a BC1/BC200 RNA-binding protein. DNA and Cell Biology 17, 751-759.   (IF 2,3).

159.   Orth. T., Mayet, W.-J., Deister, H., Schmitz, M., Chang, S.H. and Bachmann, M. (1998). Analysis of epitope spreading over an eleven – years period in a patient with systemic lupus erythematosus. Scand. J. Rheumatol. 27, 461-467.                                                                                                                                                                                                                   (IF 2,5).

160.   Chang, S. H., Huh, M. S., Kim, H. R., Kim, I. S., Kim, S. G., Lee, J. S., Grölz, D. and Bachmann, M. (1998). Cross-reactivity of antibodies immunoadsorbed to laminin with recombinant human La (SS-B) protein. J. Autoimmunity, 11, 163-171.                                                                                                                                                                                                                  (IF 7,2).

161.   Grölz, D., Tröster, H. Semsei, I. and Bachmann, M. (1998). Analysis of expression of the La/SS-B gene using reportergene constructs. Biochem. Biophys. Acta 1396, 278-293.                                                                                                (IF 3,5).

162.   Yiannaki, E. E., Tzioufas, A. G., Bachmann, M., Hantoumi, J., Sakarellos-Daitsiotis, Sakarellos, C. and Moutsopoulos, H. M. (1998). The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB. Specificity, sensitivity and comparison of methods. Clin. Exp. Immunol. 112, 152-158.                             (IF 3,0).

1997 (IF 36)

163.   Berger, C., Reinhardt, S., Rentrop, M., Bachmann, M., Weiser, T., Link, E., Wienrich, M., Jahn, R. and Maelicke, A. (1997). De novo acquisition of neuronal polarity in retinoic acid-induced embryonal carcinoma cells. Eur. J. Cell Biol. 74, 230-245.                                                                                                                                                                                               (IF 3,3).

164.   Schmitz, M., Bachmann, M., Thyssen, J. and Pruijn, G.J.M. (1997). Description of monoclonal antibodies to the autoantigen Ro52. Clin. Exp. Immunol. 110, 53-62.                                                                                                    (IF 3,0).

165.   Schmid, C., Reifferscheid, G., Zahn, R. K. and Bachmann, M. (1997). Increase of sensitivity and validity of the SOS/umu-test after replacement of the ß-galactosidase reportergene with luciferase. Mutation Research 394, 9-16.                                                                                                                                                                                                          (IF 2,2).

166.   Grölz, D. and Bachmann, M. (1997). An altered distribution of the autoantigen La/SS-B when translated from a La mRNA isoform. Exp. Cell Res. 234, 329-335.                                                                                                          (IF 3,6).

167.   Grölz, D., Bartsch, H., Tröster, H. and Bachmann, M. (1997). The nuclear autoantigen La/SS-B: Mapping and Sequencing of the gene and the three retropseudogenes. Gene 191, 23-29.                                                                             (IF 2,4).

168.   Bachmann, M., Klein, R.R., Tröster, H. and Grölz, D.  (1997). Localization of N- and C-terminal peptides of the nuclear autoantigen La translated from a mRNA containing a frame shift mutation. Biochem. Biophys. Acta 1356, 53-63.                                                                                                                                                                                                               (IF 3,5).

169.   Hühn, P., Pruijn, G.J.M., van Venrooij, W.J. and Bachmann, M. (1997). Characterization of the autoantigen La/SS-B as dsRNA unwinding enzyme. Nucleic Acids Res. 25, 410-416.                                                                      (IF 7,5).

170.   Grölz, D. and Bachmann,  M. (1997). The nuclear autoantigen La/SS-B: One gene three functional La mRNAs.  Biochem. J. 323, 151-158.                                                                                                                                               (IF 5,2).

171.   Grölz, D., Laubinger, J., Willmer, F., Tröster, H. and Bachmann, M. (1997). The nuclear autoantigen La/SS-B: Transfection analysis of expression of mRNA isoforms. J. Biol. Chem. 272, 12076-12082.                                                (IF 5,3).

1996 (IF 16,7)

172.   Bachmann, M., Grölz, D., Bartsch, H. and Tröster, H. (1996). A frame shift mutation in a hot spot region of the nuclear autoantigen La (SS-B). J. Autoimmunity  9, 747-756.                                                                                     (IF 7,2).

173.   Bachmann, M., Hilker, M., Grölz, D., Tellmann, G., Hake, U., Kater, L., deWilde, P. and Tröster, H. (1996). Different La mRNA isoforms are expressed in salivary gland tissue of patients with primary Sjögrens Syndrome. J. Autoimmunity 9, 757-766.                                                                                                                                                                        (IF 7,2).

174.   Hilker, M., Tröster, H., Grölz, D. and Bachmann, M. (1996). The autoantigen La/SS-B: Analysis of expression of alternatively spliced La mRNA isoforms.  Cell and Tissue Research 284, 383-389.                                            (IF 2,3).

1995 (IF 10,5)

175.   Tröster, H., Bartsch, H., Metzger, T.E., Klein, R., Pollak, G., Semsei, I., Pfeifer, K., Schwemmle, M., Pruijn, G.J.M., van Venrooij, W.J. and Bachmann, M. (1995).  Activation of An Autoreactive B-Cell by Immunization of a Balb/C An Mouse with Human Recombinant La Protein: Characterization of the Autoepitope. J. Autoimmunity  8,  825-842.                                                                                                                                                                                                                     (IF 7,2).

176.   Tröster, H., Semsei, I., Müller, W.E.G. and Bachmann, M. (1995). A possible cloning artefact occuring during unidirectional cDNA cloning in the Uni-ZAP XR vector system. Anal. Biochem. 225, 366-368.                                             (IF 3,3).

1994 (IF 25,9)

177.   Tröster, H., Metzger, Th., Semsei, I., Schwemmle, M., Winterpacht, A., Zabel, B. and Bachmann, M. (1994). One gene two transcripts.: Isolation of an alternative transcript encoding for the autoantigen La/SS-B from a cDNA library of a patient with primary Sjoegrens' syndrome. J. Exp. Med. 180, 2059-2067.                                                                                 (IF 14,5).

178.   Rose, O., Maelicke, S.R., Bachmann, M., Cramer, M., Rotter, M. and Starzinski-Powitz, A. (1994). M-cadherin, a selective cell surface marker for determined myogenic cells in prenatal mouse development. Developmental  Dynamics 201, 245-259.                                                                                                                                                                                (IF 2,8).

179.   Jeffrey, I.W., Schwemmle, M., Metzger, T., Bachmann, M., Hovanessian, A.G. and Clemens, M. (1994). Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells.   Exp. Cell Res. 218, 17-27.                                                                                                                                                                                    (IF 3,6).

180.   Pyne C. K,  Loones, M. T., Simon, F., Geraud, G., Bachmann, M. and Lacroix, J.C. (1994). Localization of antigens Pw33 and La on lamprush chromosomes and on nucleoplasmic structures in the oocyte of the urodele Pleurodeles waltl: Light and electron microscopic immunocytochemical studies. Chromosoma 103, 475-485.                                     (IF 5,0).

1993 (IF 12,3)

181.   Mundlos, S., Pelletier, J., Darveau, A., Bachmann, M., Winterpacht, A. and Zabel, B. (1993). Nuclear localization of the protein encoded by the Wilms' tumor gene wt1 in embryonic and adult tissues. Development 119, 1329-1341.                                                                                                                                                                                                            (IF 7,2).

182.   Pfeifer, K., Bachmann, M., Schröder, H.C., Forrest, J. and Müller, W.E.G. (1993). Prion Protein Expression in Uninfected and Scrapie-infected N2a Mouse Neuroblastoma Cells.  Cell Biochem. Function 11, 1-11.                            (IF 1,5).

183.   Schäfer, P., Aitke, S.J.M., Bachmann, M., Agutter, P.S., Müller, W.E.G. and Prochnow, D. (1993). Immunological evidence for the localization of a 110 kDa poly(A) binding protein from rat liver in nuclear envelopes and its phosphorylation by proteinkinase C. Cell. Mol. Biol. 39, 703-714.                                                           (IF 1,2).

184.   Semsei, I., Tröster, H., Schwemmle, M. and Bachmann, M. (1993). Cloning of the autoantigen La/SS-B from a rat cDNA library: Detection of species specific variations. Gene 126, 265-268.                                                       (IF 2,4).

1992 (IF 28,3)

185.   Engel, M., Bachmann, M., Schröder, H.C., Rinkevich, B., Kljajic, Z., Uhlenbruck, G. and Müller, W.E.G. (1992). A Novel Galactose- and Arabinose-specific Lectin from the Sponge Pellina semitubulosa: Isolation, Characterization and Immunobiological Properties. Biochimie 74, 27-38.                                                                                                       (IF 3,9).

186.   Schwemmle, M., Clemens, M., Hilse, K., Tröster, H., Müller, W.E.G., and Bachmann, M. (1992). Comparison of the localization of EBER RNAs in mitotic and interphase cells. Proc. Natl. Acad. Sci. USA 89, 10292-10296.                                                                                                                                                                                                                       (IF 9,4).

187.   Bachmann, M., Zaubitzer, Th. and Müller, W.E.G. (1992). Presentation and uptake of the nuclear autoantigen La/SSB by mitotic cells. Exp. Cell Res. 201, 387-398.                                                                                                   (IF 3,6).

188.   Bachmann, M., Althoff, H., Tröster, H., Selenka, C., Falke, D. and Müller, W.E.G. (1992). Translocation of the nuclear autoantigen La to the cell surface of Herpes simplex type 1 infected cells. Autoimmunity 12, 37-45.                                                                                                                                                                                                                                     (IF 2,8).

189.   Kienzle, N., Ender, M., Buck, M., Siakkou, A., Jahn, S., Petzold, G., Schneeweis, K.E., Bachmann, M.,  Müller, W.E.G., Müller-Lantsch, N. (1992). Expression of HIV-1 Nef protein in the baculovirus system: Subcellular localization and detection of antibodies against Nef in the sera of infected individuals. Arch. Virol. 126, 293-301.                       (IF 1,9).

190.   Kurelec, B., Krca, S., Pivcevic, B., Ugarkovic, D., Bachmann, M. and Müller, W.E.G. (1992). Expression of P-glycoprotein gene in marine sponge. Identification and characterization of the 125-kda drug binding glycoprotein. Carcinogenesis 13, 69-76.                                                                                                                                                                                   (IF 4,8).

191.   Kienzle, N., Bachmann, M., Müller, W.E.G. and Müller-Lantsch, N. (1992). Expression  and  cellular localization of the Nef protein from human immunodeficiency virus-1 in stably transfected B-cells. Arch. Virol. 124, 123-132.                                                                                                                                                                                                                         (IF 1,9).

1991 (IF 20,4)

192.   Weiler, B.E., Schäcke, Bachmann, M., Mills, J., Gilbert, M., Brigido, L., Matthes, E., Forrest, J. and Müller, W.E.G. (1991). Human  immunodeficiency virus: Novel enzyme-linked immunoassays for the quantitation of envelope glycoprotein 120. Application in diagnosis and drug screening. J. Virol. Methods 32, 287-301.                                         (IF 2,1).

193.   Kreuter, M.H., Robitzki, A., Chang, S.H., Steffen, R., Michaelis, M., Klajic, Z., Bachmann, M., Schröder, H.C. and Müller, W.E.G. (1991). Production of the cytostatic agent, aeroplysinin by the sponge Verongia aerophoba in in vitro culture. Comp. Biochem. Physiol. 101C, 183-187.                                                                                                                    (IF 2,6).

194.   Pfeifer, K., Bachmann, M., Schröder, H.C., Weiler, B.E., Ugarkovic, D., Okamoto, T. and Müller, W.E.G., (1991). Formation of a small ribonucleoprotein particle between Tat protein and TAR element in human deficiency virus-infected cells. J. Biol. Chem. 266, 14620-14626.                                                                                                                               (IF 5,3).

195.   Pfeifer, K., Weiler, B., Bachmann, M., Schröder, H.C. and Müller, W.E.G. (1991). Evidence for a direct interaction of Rev protein with the nuclear envelope mRNA translocation system. Eur. J. Biochem. 199, 53-64.                       (IF 3,0).

196.   Bachmann, M., Chang, S., Bernd, A., Mayet, W., Meyer zum Büschenfelde, K.-H. and Müller, W.E.G. (1991). Assembly and dissambly of the nuclear autoantigen La with the extracellular matrix. Autoimmunity 9, 99-107.                                                                                                                                                                                                                                     (IF 2,8).

197.   Schröder, H.C., Ugarkovic, D., Langen,  P., Bachmann, M., Dorn, A., Kuchino, Y. and Müller, W.E.G. (1991).  Evidence for involvement of a nuclear-envelope-asssociated RNA helicase activity in nucleocytoplasmic RNA transport. J. Cell. Physiol. 145, 136-146.                                                                                                                                                              (IF 4,6).

1990 (IF 40)

198.   Schröder, H.C., Wenger, R., Ugarkovic, D., Friese, U., Bachmann, M. and Müller, W.E.G. (1990). Differential effect of insulin and epidermal growth factor on mRNA translocation system and transport of specific poly(A)+mRNA and poly(A)-mRNA  in isolated nuclei. Biochemistry, 29, 2368-2378.                                                                                                           (IF 3,2).

199.   Bachmann, M., Chang, S., Slor, H., Schröder, H.C. and Müller, W.E.G. (1990). Shuttling of autoantigen La between nucleus and cell surface after UV irradiation of human keratinocytes. Exp. Cell Res. 191, 171-180.                           (IF 3,6).

200.   Bachmann, M., Falke, D. and Müller, W.E.G. (1990). Is La Protein involved in autoimmunization and inflammatory events during disease? Characterization of La Protein as an Unwinding enzyme. Mol. Biol. Rep. 14, 49-50.                                                                                                                                                                                                                                   (IF 2,0).

201.   Bachmann, M., Pfeifer, K., Schröder, H.C. and Müller, W.E.G. (1990). Characterization of the autoantigen La as a nucleic acid dependent ATPase/dATPase with melting properties. Cell 60, 85-93.                                                              (IF 31,2).

1989 (IF 18,7)

202.   Diehl-Seifert, B., Amberger, V., Gramzow, M., Batel, R., Bachmann, M., Schröder, H.C. and Müller, W.E.G. (1989). Directed migration of cells from the sponge Geodia cydonium. Tissue and Cell, 21, 25-36.                                           (IF 1,0).

203.   Schröder, H.C., Amberger, V., Renneisen, K., Bachmann, M., Kurelec, B., Uhlenbruck, G. and Müller, W.E.G. (1989). Protein kinase C phosphorylates the sponge aggregation receptor after its binding to the homologous aggregation factor. Europ. J. Cell Biol. 48, 142-149.                                                                                                                                      (IF 3,3).

204.   Schröder, H.C., Friese, U., Bachmann, M., Zaubitzer, T. and Müller, W.E.G. (1989). Energy requirement and kinetics of transport of poly(A)-free  histone   mRNA   compared   to   poly(A)-containing  mRNA from  isolated  L-cell nuclei. Europ. J. Biochem. 181, 149-158.                                                                                                                                     (IF 3,0).

205.   Schröder, H.C., Falke, D., Weise, K., Bachmann, M., Carmo-Fonseca, M., Zaubitzer, T. and Müller, W.E.G. (1989). Change of processing and nucleo-cytoplasmic transport of mRNA in HSV-1-infected cells. Viral Res. 13, 61-78.                                                                                                                                                                                                                                     (IF 2,6).

206.   Carmo-Fonseca, M., Pfeifer, K., Schröder, H.C., Vaz, M.F., Fonseca, J.E., Müller, W.E.G. and Bachmann, M. (1989). Identification of La ribonucleoproteins as a component of interchromatin granules. Exp Cell Res. 185, 73-85.                                                                                                                                                                                                                 (IF 3,6).

207.   Bachmann, M., Falke, D., Schröder, H.C. and Müller, W.E.G. (1989). Intracellular distribution of the La-antigen in CV-1 cells after Herpes simplex type 1 infection compared with the localization of U snRNPs. J. gen. Virol. 70, 881-889.                                                                                                                                                                                                              (IF 3,3).

208.   Bachmann, M., Pfeifer, K., Schröder, H.C. and Müller, W.E.G. (1989). The La antigen shuttles between the nucleus and the cytoplasm in CV-1 cells. Mol. Cell Biochem. 85, 103-114.                                                                   (IF 1,9).

1988 (IF 10,2)

209.   Voth, R., Rossol, S., Hess, G., Laubenstein, H.P., Meyer zum Büschenfelde, K.-H., Schröder, H.C., Bachmann, M., Reuter, P. and Müller, W.E.G. (1988). Induction of  Interferon  by  Avarol  in  human  peripheral  blood  lymphocytes.  J.  Cancer Res. 79, 647-655.                                                                                                                                                      (IF 2,5).

210.   Mayet, W.J., Bachmann, M., Pfeifer, K., Schröder, H.C., Müller, W.E.G., Gudat, W., Korting, W. and Meyer zum Büschenfelde, K.-H. (1988). A monoclonal Ro-antibody and a serum of a  Ro-positive patient with subacute cutaneous lupus erythematosus react with basal layers of human epidermis. Eur. J. Clin. Invest. 18, 465-471.                           (IF 2,6).

211.   Schröder, H.C., Rottmann, M., Wenger, R., Bachmann, M., Dorn, A. and Müller, W.E.G. (1988). Studies on protein kinases involved in regulation of nucleocytoplasmic mRNA transport. Biochem. J. 252, 777-790.                                                                                                                                                                                                                                                    (IF 5,1).

1987 (IF 21,8)

212.   Schröder, H.C., Messer, R., Bachmann, M., Bernd, A. and Müller, W.E.G. (1987). Superoxide radical-induced loss of nuclear restriction of immature mRNA: A possible cause for ageing. Mech. Ageing Dev. 41, 251-266.                                                                                                                                                                                                                                                     (IF 4,2).

213.   Schröder, H.C., Trölltsch, D., Wenger, R., Bachmann, M., Diehl-Seifert, B. and Müller, W.E.G. (1987). Cytochalasin B selectively releases ovalbumin mRNA precursors but not the mature ovalbumin mRNA from hen oviduct nuclear matrix. Eur. J. Biochem. 167, 239-245.                                                                                                                                 (IF 3,0).

214.   Schröder, H.C., Trölltsch, D., Friese, U., Bachmann, M. and Müller, W.E.G. (1987). Mature mRNA is selectively released from the  nuclear matrix by an ATP/dATP-dependent mechanism sensitive to topoisomerase inhibitors. J. Biol. Chem. 262, 8917-8925.                                                                                                                                                                        (IF 5.9).

215.   Müller, W.E.G., Weissmann, N., Bachmann, M. and Schröder, H.C. (1987). Deoxyspergualin, a potent antitumor agent: further studies on the cytobiological mode of action. J. Antibiotics 40, 1028-1035.                                                   (IF 1,6).

216.   Bachmann, M., Pfeifer, K., Schröder, H.C. and Müller, W.E.G. (1987). The nucleocytoplasmic Shuttling of the La antigen in CV-1 cells. Mol. Biol. Rep. 12, 239-240.                                                                                                   (IF 2,0).

217.   Bachmann, M., Mayet, W.J., Schröder, H.C., Pfeifer, K., Meyer zum Büschenfelde, K.-H. and Müller, W.E.G. (1987). Identification of the Ro and La antigen in the endoribonuclease VII RNP complex. Biochemical J. 243, 189-194.                                                                                                                                                                                                           (IF 5,1).

1986 (IF 34,1)

218.   Schröder, H.C., Becker, R., Bachmann, M., Gramzow, M., Seve, A.-P., Monsigny, M., Gramzow, M. and Müller, W.E.G. (1986). Differential changes of nuclear-envelope associated enzyme activities involved in nucleocytoplasmic mRNA transport in the developing rat brain and liver. Biochim. Biophys. Acta 868, 108-118.                       (IF 3,5).

219.   Schröder, H.C., Rottmann, M., Bachmann, M., Müller, W.E.G., McDonald, A.R. and Agutter, P.S. (1986). Proteins from rat liver cytosol which stimulate mRNA transport. Purification and interactions with the nuclear envelope mRNA translocation system. Eur. J. Biochem. 159, 51-59.                                                                                                                            (IF 3,0).

220.   Schröder, H.C., Rottmann, M., Bachmann, M. and Müller, W.E.G. (1986). Purification and characterization of the major NTPase from rat liver envelopes. J. Biol. Chem. 261, 663-668.                                                                  (IF 5.3).

221.   Gramzow, M., Bachmann, M., Uhlenbruck, G., Dorn, A. and Müller, W.E.G. (1986). Identification and further characterization of the specific cell binding fragment from sponge aggregation factor. J. Cell Biol. 102, 1344-1349.                                                                                                                                                                                                                                   (IF 9,6).

222.   Bachmann, M., Falke, D., Preuhs, J., Schröder, H.C., Pfeifer, K. and Müller, W.E.G. (1986). Occurence of novel small RNAs with concomitant inhibition of host cellular U small nuclear RNA synthesis in Vero cells infected with Herpes simplex virus  type 1. J. gen. Virol. 67, 2587-2594.                                                                                                                            (IF 3.3).

223.   Bachmann, M., Mayet, W.J., Schröder, H.C., Pfeifer, K., Meyer zum Büschenfelde, K.-H. and Müller, W.E.G. (1986). Association of La and Ro antigens with intracellular structures in HEp-2 carcinoma cells. Proc. Natl. Acad. Sci. USA 83, 7770-7774.                                                                                                                                                                        (IF 9,4).

224.   Bachmann, M., Schröder, H.C., Wagner, K.G., Mayet, W.J., Pfeifer, K. and Müller, W.E.G. (1986). Purification and characterization of the Ro and La antigens. Modulation of their binding affinity to poly(U) by phosphorylation and the presence of ATP. Biol. Chem. Hoppe-Seyler 367, 671-680.

1985 (IF 3,6)

225.   Bachmann, M., Maidhof, M., Schröder, H.C., Pfeifer, K., Kurz, E.M., Rose, T., Müller, I. and Müller, W.E.G. (1985). Prochloron (Prochlorophyta): Biochemical contributions  to the chlorophyll and RNA composition. Plant Cell Physiol. 26, 1211-1222.                                                                                                                                                                  (IF 3,6).

1984 (IF 16,5)

226.   Schröder, H.C., Bachmann, M., Bernd, A., Zahn, R.K. and Müller, W.E.G. (1984). Age-dependent changes of nuclear envelope protein phosphokinase and protein phosphatase activities. Significance for altered nucleo-cytoplasmic mRNA translocation during development. Mech. Ageing Dev. 27, 87-95.                                                                     (IF 4,2).

227.   Müller, W.E.G., Zahn, R.K., Maidhof, A., Schröder, H.C., Bachmann, M. and Umezawa, H. (1984). Synergistic effect of peplomycin in combination with bleomycin on L5178y mouse lymphoma cells  in vivo. J. Antibiotics 37, 239-243.                                                                                                                                                                                                                     (IF 1,5).

228.   Bachmann, M., Schröder, H.C., Bernd, A. and Müller, W.E.G. (1984). Alternsabhängige Gen-Induktion im Wachtelovidukt. Rolle posttranskriptionaler Veränderungen für den Alternsprozeß. Z. Geront. 17, 78-84.                                                                                                                                                                                                                                                 (IF 0,8).

229.   Bachmann, M., Messer, R., Trautmann, F. and Müller, W.E.G. (1984). 12S small nuclear ribonucleoprotein-associated acidic and pyrimidine-specific endoribonuclease from calf thymus and L5178y cells. Biochem. Biophys. Acta 783, 89-99.                                                                                                                                                                                                       (IF 3,5).

230.   Bachmann, M., Schröder, H.C., Messer, R. and Müller, W.E.G. (1984). Base-specific ribonucleases potentially involved in heterogeneous nuclear RNA processing and poly(A) metabolism. FEBS Letters 171, 25-30.                           (IF 3,0).

231.   Bachmann, M., Bernd, A., Schröder, H.C., Zahn, R.K. and Müller, W.E.G. (1984). The role of protein phosphokinase and protein phosphatase during the nuclear envelope nucleoside triphosphatase reaction. Biochem. Biophys. Acta 773, 308-316.                                                                                                                                                                           (IF 3,5).

1983 (IF 11,5)

232.   Müller, W.E.G., Geisert, M., Zahn, R.K., Maidhof, A., Bachmann, M. and Umezawa, H. (1983). Potentiation of the cytostatic effect of bleomycin on L5178y mouse lymphoma cells by pepleomycin.  Eur. J. Cancer Clin. Oncol. 5, 665-670.

233.   Dawes, K.W., Bachmann, M., Zahn, R.K. and Müller, W.E.G. (1983). Chromatin structure from the marine sponge Geodia cydonium. Comp. Biochem. Physiol. 76B, 769-775.                                                                                 (IF 1,6).

234.   Dawes, K.W., Bachmann, M., Zahn, R.K. and Müller, W.E.G. 1983). Partial  of a chromatin bound  endonuclease from the marine sponge Geodia cydonium. Comp. Biochem. Physiol. 76B, 763-768.                                                     (IF 1,6).

235.   Bachmann, M., Trautmann, F., Messer, R. Zahn, R.K., Meyer zum Büschenfelde, K.H. and Müller, W.E.G. (1983). Association of a polyuridylate-specific endoribonuclease with small nuclear ribonucleoproteins which had been isolated by affinity chromatography using antibodies from a patient with systemic lupus erythematosus. Eur. J. Biochem. 136, 447-451.                                                                                                                                                                               (IF 3,0).

236.   Bachmann, M., Zahn, R.K. and Müller, W.E.G. (1983). Purification and properties of a novel pyrimidine-specific endoribonuclease VII from Calf thymus that is modulated by polyadenylate. J. Biol. Chem. 258, 7033-7040.                                                                                                                                                                                                                     (IF 5.3).